calreticulin (Columbia University/Columbia Technology Ventures)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namecalreticulin (Columbia University/Columbia Technology Ventures)
Drug Alias Namecalreticulin
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionFactor IIa modulatorsCalreticulin stimulantsCoagulation factor IX modulators
TargetsCalreticulinProthrombinCoagulation factor IX
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesColumbia Technology VenturesColumbia University
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A